SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$32.88−0.44 (-1.32%)
Close on Nov 13, 2026Market cap $1.10BP/E –Yield –
SpyGlass Pharma total assets
Total assets on the balance sheet at the end of each period.
SpyGlass Pharma's total assets was $226.35M at Sep 30, 2026. For fiscal 2025 it was $115.87M, up 396.9% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $115.87M | +396.9% |
| FY2024 | Dec 31, 2024 | $23.32M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $226.35M | +870.7% |
| Q2 FY2026 | Jun 30, 2026 | $243.43M | – |
| Q1 FY2026 | Mar 31, 2026 | $258.39M | – |
| Q4 FY2025 | Dec 31, 2025 | $115.87M | – |
| Q4 FY2024 | Dec 31, 2024 | $23.32M | – |
See a number that looks wrong?